Logo
x

Search

Subscribe Now

Cell

Bayer to Acquire BlueRock Therapeutics for its Cell Therapies

Bayer to Acquire BlueRock Therapeutics for its Cell Therapies

  • August 9, 2019
Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China

Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China

  • March 20, 2019
ELIAS Animal Health Reports USDA’s Full Approval of ELIAS Cancer Immunotherapy (ECI) for Canine Osteosarcoma

    ELIAS Animal Health Reports USDA’s Full Approval of ELIAS Cancer Immunotherapy (ECI) for Canine Osteosarcoma

    • March 20, 2025
    Sanofi to Acquire Dren Bio’s Bispecific Antibody DR-0201 for ~$1.9B

      Sanofi to Acquire Dren Bio’s Bispecific Antibody DR-0201 for ~$1.9B

      • March 20, 2025
      EMA Marketing Authorization of New Drugs in February 2025

        EMA Marketing Authorization of New Drugs in February 2025

        • March 18, 2025
        AstraZeneca to acquire EsoBiotec for ~$1B

          AstraZeneca to acquire EsoBiotec for ~$1B

          • March 18, 2025
          BMS Reports the EC’s Approval of Breyanzi to Treat R/R Follicular Lymphoma

            BMS Reports the EC’s Approval of Breyanzi to Treat R/R Follicular Lymphoma

            • March 17, 2025
            Celltrion launches SteQeyma (Biosimilar, Stelara) in the US

              Celltrion launches SteQeyma (Biosimilar, Stelara) in the US

              • March 13, 2025
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.